Vonoprazan/amoxicillin

< Vonoprazan

Vonoprazan/amoxicillin
Combination of
VonoprazanPotassium-competitive acid blocker
AmoxicillinBeta-lactam antibiotic
Clinical data
Trade namesVoquezna Dual Pak
License data
Routes of
administration		By mouth
ATC code
Legal status
Legal status

Vonoprazan/amoxicillin, sold under the brand name Voquezna Dual Pak among others, is a co-packaged medication used for the treatment of Helicobacter pylori (H. pylori) infection. It contains vonoprazan (as the fumarate), a potassium-competitive acid blocker and amoxicillin, a beta-lactam antibiotic. It is taken by mouth.

The co-packaged medication was approved for medical use in the United States in May 2022.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.